Live from the NIH registry
Studies recruiting near Birmingham right now
Top 25 of 975 recruiting studies, sorted by proximity — each links to its official registry page
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AB Science
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Birmingham, Alabama (0.6 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
Abdominal Aortic Aneurysms
N/A
Observational 200 participants sought
UAB - University of Alabama in Birmingham Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: ViTAA Medical Solutions
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Centers of Alabama — Homewood, Alabama (3.9 mi)
· Sponsor: Pacific Edge Limited
Providing an Optimized and Empowered Pregnancy for You (POPPY) Aim 3: Randomized Controlled Trial
Pregnancy Complications, Maternal Distress
N/A
Interventional 400 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Radiation Free Study
Aortic Aneurysm
N/A
Interventional 182 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
004 — Birmingham, Alabama (0.6 mi)
· Sponsor: Corcept Therapeutics
Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
HIV Prevention, HIV Risk
N/A
Interventional 125 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
Extreme Prematurity, Enteral Nutrition
Phase 1, Phase 2
Interventional 150 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Process-Based Approach Case Series For Anxiety Problems
Anxiety
N/A
Interventional 10 participants sought
University of Alabama at Birmingham Dr. Borgogna's lab — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: New York Medical College
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Veterans Administration Medical Center - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Advanced or Metastatic Colorectal Cancer
Phase 1, Phase 2
Interventional 225 participants sought
O Neal Comprehensive Cancer Center at UAB — Birmingham, Alabama (0.6 mi)
· Sponsor: Janssen Research & Development, LLC
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Jaeb Center for Health Research
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Urology Centers Of Alabama Pc — Homewood, Alabama (3.9 mi)
· Sponsor: Novartis Pharmaceuticals
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Alabama Oncology — Birmingham, Alabama (0.6 mi)
· Sponsor: Revolution Medicines, Inc.
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Birmingham, AL — Birmingham, Alabama (0.6 mi)
· Sponsor: Mediar Therapeutics
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 105 participants sought
University of Alabama At Birmingham Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: BeOne Medicines
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Annovis Bio Inc.
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Complex Congenital Heart Defect, Dysfunctional RVOT Conduit
N/A
Interventional 108 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Edwards Lifesciences
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain
Knee Osteoarthritis
N/A
Interventional 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Birmingham, Alabama (0.6 mi)
· Sponsor: TG Therapeutics, Inc.
Brain Uptrain to Improve Learning and Development
Term Infant, Late Preterm Infant
N/A
Interventional 188 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham